Enhanced anti-tumor activity of interferon-alpha in SOCS1-deficient mice is mediated by CD4⁺ and CD8⁺ T cells.
about
Tumour-promoting role of SOCS1 in colorectal cancer cellsSynergistic immunotherapeutic effects of Lycium barbarum polysaccharide and interferon-α2b on the murine Renca renal cell carcinoma cell line in vitro and in vivo.Cigarette smoke-induced lung inflammation in COPD mediated via LTB4/BLT1/SOCS1 pathwayDysregulation of SOCS-Mediated Negative Feedback of Cytokine Signaling in Carcinogenesis and Its Significance in Cancer Treatment.Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities.Combining MPDL3280A with adoptive cell immunotherapy exerts better antitumor effects against cervical cancer.IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.A novel therapeutic approach for esophageal squamous cell carcinoma: suppressor of cytokine signaling-1 gene therapy.Interferon-α adjuvant therapy decreases the recurrence of early clear cell renal cell carcinoma and improves the prognosis of Chinese patients.Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study).Resveratrol Suppresses Matrix Metalloproteinase-2 Activation Induced by Lipopolysaccharide in Mouse Osteoblasts via Interactions with AMP-Activated Protein Kinase and Suppressor of Cytokine Signaling 1
P2860
Q36099348-EA9FFFAB-50E4-43D7-B23C-18C3CDF2B43AQ36224768-8C699B09-B238-472E-858D-EE2D4B1090A7Q36412757-FDDDFE87-B157-4E42-86BD-AFD6A3F6C1F9Q37630276-6AA5A19A-31CC-4488-B0D3-6BBB597ADEE9Q38733117-0A75E2EA-E7B6-41FC-B200-6D8DE075F190Q39277283-FC71396E-5508-4A69-A3F8-2F1C7871E1ABQ40503359-8EC717DB-C18E-4FA0-AD10-C430583CC503Q42332755-F4227DDE-44CE-49F1-8E58-BD30060B9DFFQ49184688-B643EF29-8E3C-4503-BED6-AB537E0D23D1Q51035013-567E33F4-0D27-4B73-A710-875DD36861CDQ58696437-92E998D5-82C0-4806-94BE-398182EAA4EA
P2860
Enhanced anti-tumor activity of interferon-alpha in SOCS1-deficient mice is mediated by CD4⁺ and CD8⁺ T cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Enhanced anti-tumor activity o ...... ated by CD4⁺ and CD8⁺ T cells.
@ast
Enhanced anti-tumor activity o ...... ated by CD4⁺ and CD8⁺ T cells.
@en
type
label
Enhanced anti-tumor activity o ...... ated by CD4⁺ and CD8⁺ T cells.
@ast
Enhanced anti-tumor activity o ...... ated by CD4⁺ and CD8⁺ T cells.
@en
prefLabel
Enhanced anti-tumor activity o ...... ated by CD4⁺ and CD8⁺ T cells.
@ast
Enhanced anti-tumor activity o ...... ated by CD4⁺ and CD8⁺ T cells.
@en
P2093
P2860
P1476
Enhanced anti-tumor activity o ...... ated by CD4⁺ and CD8⁺ T cells.
@en
P2093
Alena Cristina Jaime-Ramirez
Bethany L Mundy-Bosse
Gregory B Lesinski
Kristan D Guenterberg
Volodymyr I Karpa
William E Carson
P2860
P2888
P304
P356
10.1007/S00262-011-1034-2
P577
2011-05-21T00:00:00Z